Prosight Management, LP Quant / Systematic

Location: DALLAS, TX

CIK: 0001617201 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $610M (100.0% shares, 0.0% debt)

Holdings (46)

New Positions (16)

Increased Positions (19)

BSX BOSTON SCIENTIFIC CORP 8.2%
Value $49.92M (+149.3%) Shares 795,547 (+278.8%) Est. Cost Unrealized
NKTR NEKTAR THERAPEUTICS 8.7%
Value $52.88M (+125.5%) Shares 735,000 (+32.5%) Est. Cost Unrealized
WGS GENEDX HOLDINGS CORP 5.5%
Value $33.62M (+369.9%) Shares 523,463 (+851.8%) Est. Cost Unrealized
STTK SHATTUCK LABS INC 5.3%
Value $32.18M (+270.2%) Shares 5,004,439 (+110.1%) Est. Cost Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 4.1%
Value $25.15M (+269.6%) Shares 76,000 (+344.2%) Est. Cost Unrealized
JANX JANUX THERAPEUTICS INC 8.1%
Value $49.34M (+49.5%) Shares 3,550,000 (+48.4%) Est. Cost Unrealized
GLPG GALAPAGOS NV 7.6%
Value $46.5M (+32.4%) Shares 1,550,000 (+44.3%) Est. Cost Unrealized
ABVX ABIVAX SA 1.9%
Value $11.69M (+410.0%) Shares 105,000 (+517.6%) Est. Cost Unrealized
PHR PHREESIA INC 1.5%
Value $9.218M (-44.2%) Shares 1,100,000 (+12.6%) Est. Cost Unrealized
TERN TERNS PHARMACEUTICALS INC 1.7%
Value $10.67M (+177.9%) Shares 202,300 (+112.9%) Est. Cost Unrealized
OKUR ONKURE THERAPEUTICS INC 1.5%
Value $8.919M (+276.5%) Shares 2,154,381 (+163.7%) Est. Cost Unrealized
PRCT PROCEPT BIOROBOTICS CORP 8.0%
Value $48.64M (+12.0%) Shares 1,945,000 (+40.9%) Est. Cost Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 2.9%
Value $17.99M (+28.7%) Shares 770,000 (+15.8%) Est. Cost Unrealized
KIDS ORTHOPEDIATRICS CORP 0.8%
Value $4.799M (+97.6%) Shares 302,399 (+121.1%) Est. Cost Unrealized
KURA KURA ONCOLOGY INC 4.5%
Value $27.29M (+3.8%) Shares 3,356,700 (+32.7%) Est. Cost Unrealized
CRBP CORBUS PHARMACEUTICALS HLDGS 1.1%
Value $6.546M (+17.6%) Shares 697,108 (+1.9%) Est. Cost Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 2.1%
Value $12.71M (+3.9%) Shares 350,000 (+33.1%) Est. Cost Unrealized
ZYME ZYMEWORKS INC 2.2%
Value $13.5M (-3.3%) Shares 539,049 (+1.6%) Est. Cost Unrealized
PLRX PLIANT THERAPEUTICS INC 0.3%
Value $2.101M (+10.7%) Shares 1,667,600 (+7.2%) Est. Cost Unrealized

Decreased Positions (10)

Unchanged Positions (1)